SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
909jpet.aspetjournals.org Vol. 301, Issue 2, 611-617, May 2002 Differential ActioMiljenko Zuanic-4/17/2002
908wimpy, and lacking insight and any attempt to actually engage in research..... scaram(o)uche-4/17/2002
907From SSB report: Neurocrine Biosciences (NBIX, Neutral, Venture) Reporting datmopgcw-4/17/2002
906What a procedure. My heart goes out to the patients who have such hard choices.keokalani'nui-4/16/2002
905Expanded PR. Based on what is NBIX trying to do, I will say :"not so fastMiljenko Zuanic-4/15/2002
904Thanks Harry, Jim. OT: Sedative-hypnotic versus anxiolytic! My comment was thaMiljenko Zuanic-4/13/2002
903Just confirming your numbers for MZ. From Dov's S1: 6.0% to Dov of which 2.rkrw-4/12/2002
902Miljenko, our figures are close but not quite matching. I have 6% royalties goinNeuroInvestment-4/12/2002
901Harry, You were correct. DOV royalty is 3.5% of net sale (+ 35% of 3.5% to WE).Miljenko Zuanic-4/11/2002
900IL-4's sister conjugate......... Wednesday April 10, 9:23 am Eastern Time scaram(o)uche-4/10/2002
899and Vol. 301, Issue 1, 333-345, April 2002 4-(2-Chloro-4-methoxy-5-methylphenyMiljenko Zuanic-4/8/2002
898jpet.aspetjournals.org Vol. 301, Issue 1, 322-332, April 2002 4-(2-Chloro-4-meMiljenko Zuanic-4/8/2002
897jpet.aspetjournals.org Vol. 301, Issue 1, 95-102, April 2002 Pharmacological PMiljenko Zuanic-4/8/2002
896>> if beta-secretase inhibitors, Antegren, and/or sonic hedgehog do not pascaram(o)uche-3/27/2002
895Still off topic........... The Curis/hedgehog protein program has some precliniNeuroInvestment-3/25/2002
894(off topic) Thanks, Harry. Acorda, CeNeS et al.? Anything that you see, deep scaram(o)uche-3/25/2002
893Rick: Sorry, I really don't follow the Elan drug delivery side at all exceptNeuroInvestment-3/25/2002
892(off topic) Harry..... no surprise to you, some of us are scrambling to deterscaram(o)uche-3/23/2002
891Tuesday March 19, 7:01 am Eastern Time Press Release SOURCE: Neurocrine BioscienMiljenko Zuanic-3/19/2002
890Yes, we all know that Rick is expert on immunology and that he was/is very cautiMiljenko Zuanic-3/7/2002
889Miljenko: I know that Rick has serious doubts about APL in MS, and he knows inNeuroInvestment-3/6/2002
888Harry, Thanks for bringing points on tox issue. For chronic CNS therapy for suMiljenko Zuanic-3/6/2002
887Miljenko: Actually, this is an example of why GSK has been moving so slowly--NSNeuroInvestment-3/6/2002
886Message 17151876 Neurosearch and Glaxo end drug tests By Nerma Jelacic FT.com, Miljenko Zuanic-3/5/2002
885Kelley, It is a SHOT at the TSC and similar bastards. However, overall can notMiljenko Zuanic-3/1/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News